Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

NCT00045006 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: vorinostat

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]